Literature DB >> 27771842

Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.

Kazuya Sugimori1, Kazushi Numata2, Masahiro Okada3, Hiromi Nihonmatsu1, Shigeo Takebayashi4, Shin Maeda5, Masayuki Nakano6, Katsuaki Tanaka1.   

Abstract

OBJECTIVE: We investigated the characteristic findings of regenerative nodules (RNs) for differentiating early hepatocellular carcinoma (HCC) from high-grade dysplastic nodules (HGDNs) using magnetic resonance imaging (MRI) with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA; EOB-MRI) and contrast-enhanced ultrasonography (CEUS) in patients with chronic liver disease. SUBJECTS AND METHODS: Pathologically confirmed lesions (100 early HCCs, 7 HGDNs, and 20 RNs with a maximum diameter of more than 1 cm and mean maximal diameters of 15.5, 15.1, and 14.8 mm, respectively) were enrolled in this retrospective study. The signal intensities of these lesions during the hepatobiliary phase of EOB-MRI were investigated, and findings characteristic of RNs using this modality were also evaluated using CEUS.
RESULTS: Ninety-eight of the 100 early HCCs that were hypo-intense (n = 95), iso-intense (n = 2), or hyper-intense (n = 1) and the seven HGDNs that were hypo-intense (n = 6) or hyper-intense (n = 1) during the hepatobiliary phase of EOB-MRI exhibited centripetal vessels during the arterial dominant phase of CEUS, although one early HCC that was hypo-intense exhibited both centrifugal and centripetal vessels. Eighteen of the 20 RNs and one early HCC that were hyper-intense with a small central hypo-intensity and the remaining two RNs that were hyper-intense on EOB-MRI exhibited centrifugal vessels during the arterial dominant phase of CEUS. The small central hypo-intense area corresponded to central vascular structures in the lesion, such as the hepatic artery and portal vein running from the center to the periphery, when viewed using CEUS.
CONCLUSION: Central vascular structures may be a characteristic finding of RNs when observed during the hepatobiliary phase of EOB-MRI and the arterial dominant phase of CEUS.

Entities:  

Keywords:  Contrast-enhanced ultrasonography; Early hepatocellular carcinoma; High-grade dysplastic nodule; Magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid; Regenerative nodule

Mesh:

Substances:

Year:  2016        PMID: 27771842     DOI: 10.1007/s10396-016-0750-9

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  29 in total

1.  Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.

Authors:  Wen Luo; Kazushi Numata; Manabu Morimoto; Akito Nozaki; Michio Ueda; Masaaki Kondo; Satoshi Morita; Katsuaki Tanaka
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

2.  Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.

Authors:  Kazushi Numata; Hiroyuki Fukuda; Hiromi Nihonmatsu; Masaaki Kondo; Akito Nozaki; Makoto Chuma; Manabu Morimoto; Takashi Oshima; Masahiro Okada; Takamichi Murakami; Shigeo Takebayashi; Shin Maeda; Yoshiaki Inayama; Masayuki Nakano; Katsuaki Tanaka
Journal:  Abdom Imaging       Date:  2015-10

3.  Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma.

Authors:  M Nakano; A Saito; M Yamamoto; M Doi; K Takasaki
Journal:  Liver       Date:  1997-02

4.  Histopathological diagnosis of early HCC through biopsy: efficacy of Victoria blue and cytokeratin 7 staining.

Authors:  Sawako Kobayashi; Soo Ryang Kim; Susumu Imoto; Kenji Ando; Makoto Hirakawa; Jun Saito; Katsumi Fukuda; Yumi Otono; Madoka Sakaki; Shinobu Tsuchida; Soo Ki Kim; Yoshitake Hayashi; Masayuki Nakano; Masatoshi Kudo
Journal:  Dig Dis       Date:  2012-12-13       Impact factor: 2.404

5.  Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation.

Authors:  J H Lim; E Y Kim; W J Lee; H K Lim; Y S Do; I W Choo; C K Park
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

6.  Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.

Authors:  A Gatto; A M De Gaetano; M Giuga; M Ciresa; L Siciliani; L Miele; L Riccardi; F Pizzolante; G L Rapaccini; A Gasbarrini; F Giuliante; F M Vecchio; M Pompili; L Bonomo
Journal:  Abdom Imaging       Date:  2013-08

7.  Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications.

Authors:  Amedeo Sciarra; Luca Di Tommaso; Masayuki Nakano; Annarita Destro; Guido Torzilli; Matteo Donadon; Marco Maggioni; Silvano Bosari; Gaetano Bulfamante; Masanori Matsuda; Hideki Fujii; Tomoaki Ichikawa; Hiroyuki Morisaka; Katsuhiro Sano; Shintaro Ichikawa; Massimo Roncalli
Journal:  J Hepatol       Date:  2015-09-05       Impact factor: 25.083

8.  Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI.

Authors:  C S van Kessel; E de Boer; F J W ten Kate; L A A Brosens; W B Veldhuis; M S van Leeuwen
Journal:  Abdom Imaging       Date:  2013-06

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Multiple FNH-Like Lesions in a Patient with Chronic Budd-Chiari Syndrome: Gd-EOB-Enhanced MRI and BR1 CEUS Findings.

Authors:  Caroline Newerla; Fabienne Schaeffer; Luigi Terracciano; Joachim Hohmann
Journal:  Case Rep Radiol       Date:  2012-03-11
View more
  7 in total

1.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

2.  Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.

Authors:  Shuhei Nishigori; Kazushi Numata; Kuniyasu Irie; Hiroyuki Fukuda; Makoto Chuma; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2018-01-23       Impact factor: 1.314

Review 3.  Application of new ultrasound techniques for focal liver lesions.

Authors:  Feiqian Wang; Kazushi Numata; Hiromi Nihonmatsu; Masahiro Okada; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2020-01-16       Impact factor: 1.314

4.  Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.

Authors:  Lian-Feng Liu; Zhan-Ling Ding; Jian-Hong Zhong; Hong-Xue Li; Jun-Jie Liu; Hang Li; Le-Qun Li
Journal:  Biomed Res Int       Date:  2018-11-07       Impact factor: 3.411

5.  Combination of acoustic radiation force impulse imaging, serological indexes and contrast-enhanced ultrasound for diagnosis of liver lesions.

Authors:  Xiao-Lan Sun; Hui Yao; Qiong Men; Ke-Zhu Hou; Zhen Chen; Chang-Qing Xu; Li-Wei Liang
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

Review 6.  MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients.

Authors:  Riccardo Inchingolo; Riccardo Faletti; Luigi Grazioli; Eleonora Tricarico; Marco Gatti; Anna Pecorelli; Davide Ippolito
Journal:  World J Hepatol       Date:  2018-07-27

7.  Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma.

Authors:  Akihiro Funaoka; Kazushi Numata; Atsuya Takeda; Yusuke Saigusa; Yuichirou Tsurugai; Hiromi Nihonmatsu; Makoto Chuma; Hiroyuki Fukuda; Masahiro Okada; Masayuki Nakano; Shin Maeda
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.